Malaysia Pharmaceuticals and Healthcare Report Q2 2014

Business Monitor International
March 19, 2014
144 Pages - SKU: BMI5217977
Countries covered: Malaysia

Malaysia Pharmaceuticals and Healthcare Report Q2 2014

BMI View: Malaysia's pharmaceutical and healthcare markets continue to show strong growth, and thegovernment's 2014 budget allocation for the healthcare sector supports BMI's optimism towards themarket. The country's private healthcare sector is attracting foreign investment and development, whichsupports the growing medical tourism market. However, the shortage of specialist medical staff and thesignificant presence of counterfeit drugs are issues the country must overcome to avoid them negativelyimpacting the industry.

Headline Expenditure Projections

Pharmaceuticals: MYR6.66bn (US$2.11bn) in 2013 to MYR7.30bn (US$2.28bn) in 2014; +9.6% inlocal currency and +7.9% in US dollars. Forecast increased in light of new budgetary data for 2014.

Healthcare: MYR38.14bn (US$12.11bn) in 2013 to MYR41.98bn (US$13.12bn) in 2014; +10.1% inlocal currency and +8.4% in US dollars. Forecast raised from Q4 2013 due to the release of the 2014budget.

Risk/Reward Rating: In Q2 2014, Malaysia's Pharmaceutical Risk/Reward Rating (RRR) stood at 60,marking no change from Q1 2014. It posts above-average scores for every indicator in the Asia Pacificregion, and ranks eighth out of 19 markets.



More Prescription Drugs reports by Business Monitor International

Sweden Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sweden Pharmaceuticals and Healthcare Report Q1 2015BMI View: Declining government reimbursement for prescription medicines does not bode well forinnovative drugmakers selling their products in Sweden, ...
Pakistan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Pakistan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Pakistan holds great potential for pharmaceutical and healthcare companies, with the world'ssixth largest population. However, poor medical ...
Nigeria Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Nigeria Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Nigerian government remains committed to improving healthcare quality andinfrastructure across the country. The formation of the ...
New Zealand Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
New Zealand Pharmaceuticals and Healthcare Report Q1 2015BMI View: With New Zealand's population ageing rapidly, underlying demand for health services andpharmaceuticals is high for the ...
See all reports like this >>

More Malaysia Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Malaysia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Malaysia Q4 2014BMI View: The Malaysian pharmaceutical and healthcare markets are set to grow significantly. Promisinglong-term economic growth, local government ...
Antibiotics Market in Malaysia to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Malaysia. The study provides essential market ...
The Pharmaceutical Market: Malaysia by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Malaysia (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!